Focusing upon the strengths in the discovery, development and manufacture of cancer medicines in the North of England through to commercialisation (patients), this event will highlight industry, academic and clinical strengths whilst showcasing key activities, infrastructure and the joined up translational environment which exists in the North.

We are delighted to have Susan Galbraith, Vice President of Oncology at AstraZeneca and Rob Bristow, Director of MCRC and Chief Academic Officer at The Christie NHS Foundation Trust as Keynote Speakers.

The event will cover sessions on:

• New Target Identification & Chemistry
• Preclinical: PK ADME, Toxicology
• Clinical Trials and how Clinical decisions made
• Pharmaceutical Development
• Imaging, Diagnostics, Pathology & Screening

Delegate Fees
Premium Bionow Member: £125.00 + VAT
Bionow Member: £155.00 + VAT
Non-Member: £250.00 + VAT

If you are interested in exhibiting at the event, please contact Helen Williams at helen.williams@bionow.co.uk for further information.